Voyager Therapeutics (VYGR) EBT (2014 - 2026)
Voyager Therapeutics (VYGR) posted EBT of -$27.9 million for Q1 2026, down 1.85% sequentially from -$27.4 million in Q4 2025, and up 9.88% YoY from -$25.4 million in Q1 2025.
Voyager Therapeutics (VYGR) EBT (2014 - 2026) Analysis & Trends
Voyager Therapeutics has reported EBT for 13 years, with the latest figure at -$27.9 million in Q1 2026.
- Quarterly EBT rose 9.88% year-over-year to -$27.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$116.5 million (down 38.7% YoY) and the FY2025 annual result came in at -$119.6 million, down 85.86% from the prior year.
- EBT slipped to -$27.9 million in Q1 2026 per VYGR's latest filing, from -$27.4 million in the prior quarter.
- Over five years, EBT peaked at $124.7 million in Q1 2023 and troughed at -$33.9 million in Q4 2024.
- A 5-year average of -$7.3 million and a median of -$22.1 million in 2023 frame the typical range for EBT.
- The sharpest annual moves came in 2022 and 2023: EBT plunged 515.6% in 2022, then jumped 685.15% in 2023.
- Over 5 years, EBT stood at -$23.6 million in 2022, then soared by 342.34% to $57.2 million in 2023, then tumbled by 159.25% to -$33.9 million in 2024, then advanced by 19.13% to -$27.4 million in 2025, then slipped by 1.85% to -$27.9 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$27.9 million, -$27.4 million, and -$27.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Voyager Therapeutics | 201.32 Mn | 84.98 Mn | - | -24.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.45 Mn |
| Mar 31, 2026 | -27.92 Mn |
| Dec 31, 2025 | -27.42 Mn |
| Sep 30, 2025 | -27.81 Mn |
| Jun 30, 2025 | -33.37 Mn |
| Mar 31, 2025 | -30.98 Mn |
| Dec 31, 2024 | -33.90 Mn |
| Sep 30, 2024 | -9.00 Mn |
| Jun 30, 2024 | -10.12 Mn |
| Mar 31, 2024 | -11.32 Mn |
| Dec 31, 2023 | 57.22 Mn |
| Sep 30, 2023 | -26.08 Mn |
| Jun 30, 2023 | -22.15 Mn |
| Mar 31, 2023 | 124.75 Mn |
| Dec 31, 2022 | -23.61 Mn |
| Sep 30, 2022 | 17.62 Mn |
| Jun 30, 2022 | -19.09 Mn |
| Mar 31, 2022 | -21.32 Mn |
| Dec 31, 2021 | 5.68 Mn |
| Sep 30, 2021 | -83.74 Mn |